Product Information

PAROXETINE ER 37.5 MG TABLET is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $0.4569 per EA under NDC 69367033730. Its NADAC has been published 268 times since Oct 6, 2021.

FDA first approved this application on Feb 16, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PAROXETINE ER 37.5 MG TABLET

Paroxetine
$0.4569per EA

Strength

37.5 mg/1

NDC

69367033730

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

PAROXETINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA213485

FDA Approved

2/16/2021

TE Code

AB

On Market Since

7/26/2021

Pharmacological Classes

Serotonin Reuptake Inhibitor
Serotonin Uptake Inhibitors

Price Statistics

The NADAC for PAROXETINE ER 37.5 MG TABLET has been published 268 times since Oct 6, 2021, and over the history we have for it it has declined 51.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4569 per EA
All-time high$1.3194 (Nov 10, 2021)
All-time low$0.3671 (Nov 20, 2024)
52-week high$0.5403
52-week low$0.3974
Median price$0.5804
Average price$0.6708
Largest weekly change+50.9% (Feb 22, 2023)
Weeks tracked268
Tracking sinceOct 6, 2021

Price History

1W

+4.0%

1M

+15.0%

3M

+14.3%

6M

+12.9%

1Y

-15.2%

3Y

-21.3%

5Y

-59.5%

All

-51.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PAROXETINE ER 37.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE ER 37.5 MG TABLET, manufactured by Westminster Pharmaceuticals LLC, is $0.4569 per EA (NDC 69367033730), effective Nov 18, 2026.

How has the price of PAROXETINE ER 37.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for PAROXETINE ER 37.5 MG TABLET has declined 51.2%. It has been tracked across 268 weekly CMS publications since Oct 6, 2021.

What are the highest and lowest recorded NADAC prices for PAROXETINE ER 37.5 MG TABLET?

Since Oct 6, 2021, the NADAC for PAROXETINE ER 37.5 MG TABLET has ranged from a low of $0.3671 (Nov 20, 2024) to a high of $1.3194 (Nov 10, 2021), with a median of $0.5804 per EA.

Are there cheaper alternatives to PAROXETINE ER 37.5 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PAROXETINE ER 37.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PAROXETINE ER 37.5 MG TABLET?

PAROXETINE ER 37.5 MG TABLET (NDC 69367033730) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.